flavipucine has been researched along with sn 38 in 1 studies
| Studies (flavipucine) | Trials (flavipucine) | Recent Studies (post-2010) (flavipucine) | Studies (sn 38) | Trials (sn 38) | Recent Studies (post-2010) (sn 38) |
|---|---|---|---|---|---|
| 6 | 0 | 3 | 85 | 1 | 43 |
| Protein | Taxonomy | flavipucine (IC50) | sn 38 (IC50) |
|---|---|---|---|
| DNA topoisomerase 1 | Homo sapiens (human) | 3.25 | |
| DNA topoisomerase 1 | Mus musculus (house mouse) | 4 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 0.176 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamo, S; Kawasaki, T; Kuramochi, K; Kusakabe, Y; Mizutani, S; Takasawa, R; Tomoshige, S; Tsubaki, K; Yoshimoto, T | 1 |
1 other study(ies) available for flavipucine and sn 38
| Article | Year |
|---|---|
Synthesis, antibacterial and cytotoxic evaluation of flavipucine and its derivatives.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacillus subtilis; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Escherichia coli; Humans; Microbial Sensitivity Tests; Molecular Structure; Pyridones; Structure-Activity Relationship | 2019 |